Three-Statement Breakdown
REVENUE UP
Revenue rose 9.7% year over year to $92.2B, and carried a 11.5% net margin.
REVENUE
+9.7%
92,189
GROSS PROFIT
—
—
NET INCOME
-13.5%
10,560
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 80,006 | 81,400 | 82,692 | 84,052 | 85,847 | 88,309 | 90,530 | 92,189 | +1.8% | +9.7% | |
| SG&A | (20,746) | (20,818) | (21,168) | (21,423) | (22,252) | (23,470) | (23,948) | (24,385) | +1.8% | +13.8% | |
| Operating income | 16,904 | 18,010 | 18,812 | 19,395 | 19,129 | 18,279 | 17,976 | 18,253 | +1.5% | -5.9% | |
| Interest expense | -3,419 | -3,411 | -3,447 | -3,515 | -3,603 | -3,774 | -3,889 | -4,022 | — | — | |
| Income tax | (3,144) | (3,373) | (3,494) | (3,709) | (3,615) | (3,289) | (3,234) | (3,265) | +1.0% | -12.0% | |
| Net income | 10,372 | 11,339 | 11,918 | 12,215 | 11,870 | 10,992 | 10,543 | 10,560 | +0.2% | -13.5% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-23 ↗